Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection

BACKGROUND: Hepatitis E virus (HEV) infection is a cause of chronic hepatitis in immunosuppressed patients. Sustained virologic response rates to a 12-wk course of ribavirin therapy were reported to be > 70% in the West. This study describes the outcome of HEV treatment in a transplant center in...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, En Xian Sarah, Tripon, Edhel, Lim, Kieron, Tan, Poh Seng, Low, How Cheng, Dan, Yock Young, Lee, Yin Mei, Muthiah, Mark, Loo, Wai Mun, Koh, Calvin Jianyi, Phyo, Wah Wah, Pang, JunXiong, Lim, Seng Gee, Lee, Guan-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603503/
https://www.ncbi.nlm.nih.gov/pubmed/31293723
http://dx.doi.org/10.4254/wjh.v11.i6.553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603503/
https://www.ncbi.nlm.nih.gov/pubmed/31293723
http://dx.doi.org/10.4254/wjh.v11.i6.553

Ejemplares similares